Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Bevacizumab in the Treatment of Metastatic Colorectal Cancer (mCRC) in Italy: an Observational Cohort Study

NCT01609075 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01609075
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01609075 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Bevacizumab in the Treatment of Metastatic Colorectal Cancer (mCRC) in Italy: an Observational Cohort Study
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
June 30, 2012
Completion date
June 30, 2013
Enrollment
437 (actual)
Sites
72

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer